InMed Pharmaceuticals Inc. Common Shares (INM) Stock Price

INMStock

$1.44−37.28%52W

Market Cap$7.69M

P/E—

PEG Ratio—

Div yield—

Beta0.96

INM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)55.23%

Price vs S&P 500 (4W)-17.42%

VGM Score39.45

Book Value / Share (Quarterly)$2.08

P/TBV (Annual)0.55x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)65.55%

Cash Flow / Share (Quarterly)$-2.25

Price vs S&P 500 (YTD)22.95%

Gross Margin (TTM)35.87%

Net Profit Margin (TTM)-170.83%

EPS (TTM)$-2.88

10-Day Avg Trading Volume0.09M

EPS Excl Extra (TTM)$-2.88

EPS (Annual)$-8.36

ROI (Annual)-60.75%

Gross Margin (Annual)34.53%

Net Profit Margin (5Y Avg)-610.28%

Cash / Share (Quarterly)$1.57

Revenue Growth QoQ (YoY)-26.22%

ROA (Last FY)-52.39%

Revenue Growth TTM (YoY)-32.84%

EBITD / Share (TTM)$-2.49

ROE (5Y Avg)-110.61%

Operating Margin (TTM)-176.99%

Cash Flow / Share (Annual)$-3.88

P/B Ratio0.69x

P/B Ratio (Quarterly)0.27x

EV / Revenue (TTM)-0.13x

Net Interest Coverage (TTM)-32.42x

ROA (TTM)-69.09%

EPS Incl Extra (Annual)$-8.36

Current Ratio (Annual)6.99x

Quick Ratio (Quarterly)2.84x

3-Month Avg Trading Volume1.77M

52-Week Price Return-37.28%

Tangible BV / Share (Quarterly)$1.63

P/S Ratio (Annual)0.96x

Asset Turnover (Annual)0.32x

52-Week High$2.50

Operating Margin (5Y Avg)-631.89%

EPS Excl Extra (Annual)$-8.36

Tangible BV CAGR (5Y)19.78%

26-Week Price Return66.47%

Quick Ratio (Annual)6.30x

13-Week Price Return-17.34%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)3.12x

Enterprise Value$-436,500

Asset Turnover (TTM)0.24x

Book Value / Share Growth (5Y)-59.12%

Inventory Turnover (Annual)2.94x

Pretax Margin (Annual)-165.14%

Cash / Share (Annual)$5.55

3-Month Return Std Dev61.18%

Gross Margin (5Y Avg)34.66%

ROE (Last FY)-60.75%

Net Interest Coverage (Annual)-5.98x

EPS Basic Excl Extra (Annual)$-8.36

P/FCF (TTM)1574.18x

Receivables Turnover (TTM)14.55x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-2.88

Receivables Turnover (Annual)12.08x

ROI (TTM)-82.01%

P/S Ratio (TTM)1.46x

Pretax Margin (5Y Avg)-610.19%

Revenue / Share (Annual)$5.06

Tangible BV / Share (Annual)$5.90

Price vs S&P 500 (52W)-55.59%

Year-to-Date Return34.91%

5-Day Price Return-0.69%

EPS Normalized (Annual)$-8.36

ROA (5Y Avg)-84.68%

Net Profit Margin (Annual)-165.14%

Month-to-Date Return-2.72%

Cash Flow / Share (TTM)$-2.20

EBITD / Share (Annual)$-7.92

Operating Margin (Annual)-160.78%

ROI (5Y Avg)-110.61%

EPS Basic Excl Extra (TTM)$-2.88

P/TBV (Quarterly)0.35x

P/B Ratio (Annual)0.48x

Inventory Turnover (TTM)2.03x

Pretax Margin (TTM)-170.83%

Book Value / Share (Annual)$6.71

Price vs S&P 500 (13W)-20.13%

Beta0.96x

P/FCF (Annual)46.62x

Revenue / Share (TTM)$0.82

ROE (TTM)-82.01%

52-Week Low$0.57

vGradeC

gGradeD

mGradeC

vgmGradeD

INM Analyst Recommendations

Nov 2022

Dec 2022

Jan 2023

Feb 2023

2.25

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
INMInMed Pharmaceuticals Inc. Common Shares	C	D	C	$1.44
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About InMed Pharmaceuticals Inc. Common Shares

InMed Pharmaceuticals is a clinical-stage Canadian biopharmaceutical company developing small molecule therapies for rare diseases, with a pipeline including candidates for epidermolysis bullosa, glaucoma, and Alzheimer's disease. The company also operates BayMedica, a commercial segment producing rare cannabinoids for the health and wellness market.